Brainstorm Cell Therapeutics BCLI
OTC BCLI
$0.77 -0.02 (-2.53%)
At close: Oct 21, 2026 · 4:00 PM EDT

Brainstorm Cell Therapeutics (BCLI) Assets (2010 - 2026)

Updated

Brainstorm Cell Therapeutics (BCLI) recorded Assets of $788,000 in Q2 2026, down 69.3% from $2.57 million a year earlier but up 4.4% from the prior quarter.

Analysis

Brainstorm Cell Therapeutics (BCLI) Assets (2010 - 2026) Analysis & Trends

At the end of FY2025, Brainstorm Cell Therapeutics reported Assets of $1.02 million, down 44.2% from FY2024.

  • Annual Assets has declined for five straight years, with a five-year compound annual growth rate of -54.3% (FY2020 to FY2025).
  • Across earlier years, Assets came in at $1.83 million in FY2024 (-56.5%), $4.21 million in FY2023 (-50.2%), $8.45 million in FY2022 (-71.1%) and $29.28 million in FY2021 (-42.9%).
  • Quarterly Assets has ranged from $755,000 in Q1 2026 to $34.54 million in Q3 2021 over the past five years.
  • On a year-over-year basis, Assets has declined for five consecutive quarters, with an average decline of 49.2% over the last eight quarters.
  • Peak year-over-year performance for Assets in the last five years was growth of 6.7% in Q1 2025, against a decline of 78.9% in Q1 2026 at the low end.
  • Per Business Quant, the preceding three quarters came in at $755,000 (Q1 2026), $1.02 million (Q4 2025) and $1.38 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Assets (Qtr)
1 Eli Lilly 1,165.22 Bn 1,133.81 Bn 19.71 Bn 142.28 Bn
2 Johnson & Johnson 646.28 Bn 566.14 Bn 17.30 Bn 197.43 Bn
3 AbbVie 503.17 Bn 476.28 Bn 12.70 Bn 135.12 Bn
4 Merck 365.23 Bn 319.60 Bn 12.21 Bn 129.80 Bn
5 Novartis Ag 302.66 Bn 266.65 Bn 11.24 Bn 122.03 Bn
6 Astrazeneca 267.39 Bn 241.08 Bn 12.86 Bn 115.83 Bn
7 Amgen 241.61 Bn 197.01 Bn 7.24 Bn 95.64 Bn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn 49.36 Bn
9 Pfizer 172.91 Bn 119.55 Bn 10.94 Bn 201.13 Bn
10 Brainstorm Cell Therapeutics 8.50 Mn 8.43 Mn - 788,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 788,000.00
Mar 31, 2026 755,000.00
Dec 31, 2025 1.02 Mn
Sep 30, 2025 1.38 Mn
Jun 30, 2025 2.57 Mn
Mar 31, 2025 3.57 Mn
Dec 31, 2024 1.83 Mn
Sep 30, 2024 2.03 Mn
Jun 30, 2024 5.68 Mn
Mar 31, 2024 3.35 Mn
Dec 31, 2023 4.21 Mn
Sep 30, 2023 5.68 Mn
Jun 30, 2023 5.75 Mn
Mar 31, 2023 7.87 Mn
Dec 31, 2022 8.45 Mn
Sep 30, 2022 13.25 Mn
Jun 30, 2022 18.96 Mn
Mar 31, 2022 25.79 Mn
Dec 31, 2021 29.28 Mn
Sep 30, 2021 34.54 Mn
API Access

Brainstorm Cell Therapeutics Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=assets&ticker=BCLI&period=max&api_key=YOUR_API_KEY